Baganday, Linlin D.

HRN: 27-74-94  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/05/2025
09/12/2025
IV
2.25
Q8
Sepsis Sec To Complicated Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines